Living With Bipolar: a web-based self management intervention

An online randomised controlled trial to assess the feasibility, acceptability and potential effectiveness of "Living With Bipolar": a web-based self-management intervention for bipolar disorder

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64826171

Enrollment

100

Registered

2011-09-12

Start date

2011-09-01

Completion date

Unknown

Last updated

2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Affective Disorder Mental and Behavioural Disorders Bipolar affective disorder

Interventions

Group 1 : Waiting list control group - participants receive normal treatment and are given access to the intervention at the end of the trial Group 2 : The 'Living with Bipolar' intervention aims to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years 2. Living in the United Kingdom 3. Have a diagnosis of Bipolar Disorder (type I or type II) by a mental health professional and meet criteria on the Mood Disorders Questionnaire (MDQ) 4. Must be able to understand written English and have access to the internet a printer and an email account

Exclusion criteria

Exclusion criteria: 1. They are aged under 18 years 2. They are living outside the United Kingdom 3. They don't have a health professional diagnosis of Bipolar Disorder and don't meet criteria on the Mood Disorders Questionnaire (MDQ) 4. They can't understand written English and don't have access to the internet, a printer or an email account

Design outcomes

Primary

Measure	Time frame
1. The primary aims of this trial are to assess the feasibility and acceptability of the LWB intervention 1.1. Feasibility will be assessed quantitatively by analysing recruitment rates and retention rates and qualitatively through the research team's experience, considering the practicalities and barriers of delivery 1.2. Acceptability will be assessed quantitatively by analysing website usage statistics including patterns and frequency of use and a specifically designed user satisfaction scale, and qualitatively in a series of in-depth qualitative interviews 2. The secondary aim is to assess the potential effectiveness of the intervention on psychological outcome 2.1. The Quality of Life in Bipolar Disorder scale (Brief version) (QOL.BD-Brief) 2.2. The World health Organisation Quality of Life assessment tool, brief version (WHOQOL-BREF) Measured at 3 months (half way through trial) and 6 months (trial end)	—

Measure

Time frame

1. The primary aims of this trial are to assess the feasibility and acceptability of the LWB intervention 1.1. Feasibility will be assessed quantitatively by analysing recruitment rates and retention rates and qualitatively through the research team's experience, considering the practicalities and barriers of delivery 1.2. Acceptability will be assessed quantitatively by analysing website usage statistics including patterns and frequency of use and a specifically designed user satisfaction scale, and qualitatively in a series of in-depth qualitative interviews 2. The secondary aim is to assess the potential effectiveness of the intervention on psychological outcome 2.1. The Quality of Life in Bipolar Disorder scale (Brief version) (QOL.BD-Brief) 2.2. The World health Organisation Quality of Life assessment tool, brief version (WHOQOL-BREF) Measured at 3 months (half way through trial) and 6 months (trial end)

—

Secondary

Measure	Time frame
1. Internal State Scale (Bauer et al., 1991) 2. Social Adaption Self-evaluation Scale (SASS) (Bosc et al., 1997) 3. Bipolar Recovery Questionnaire (Jones, In Preparation) 4. The Brief Illness perception questionnaire (BIPQ) adapted for Bipolar Disorder (Broadbent et al., 2006) 5. The Self Efficacy for Managing Chronic Disease Scale, Brief Version (Lorig et al., 2001) 6. The Hayward Stigma and Self Esteem Questionnaire (Hayward et al., 2002) 7. Hypomanic Interpretations Questionnaire (HIQ-10) (Jones et al., 2006) 8. Interpretations of Depression Questionnaire (IDQ-10) (Jones & Day, 2008) 9. Coping Inventory for Prodromes of Mania (Wong & Lam, 1999) 10. Response Styles to Depression Questionnaire (Nolen-Hoeksema & Morrow, 1991) 11. Stephenson Medication Adherence Interview (Stephenson et al., 1993) adapted for use as a self-report instrument Measured at 3 months (half way through trial) and 6 months (trial end)	—

Measure

Time frame

1. Internal State Scale (Bauer et al., 1991) 2. Social Adaption Self-evaluation Scale (SASS) (Bosc et al., 1997) 3. Bipolar Recovery Questionnaire (Jones, In Preparation) 4. The Brief Illness perception questionnaire (BIPQ) adapted for Bipolar Disorder (Broadbent et al., 2006) 5. The Self Efficacy for Managing Chronic Disease Scale, Brief Version (Lorig et al., 2001) 6. The Hayward Stigma and Self Esteem Questionnaire (Hayward et al., 2002) 7. Hypomanic Interpretations Questionnaire (HIQ-10) (Jones et al., 2006) 8. Interpretations of Depression Questionnaire (IDQ-10) (Jones & Day, 2008) 9. Coping Inventory for Prodromes of Mania (Wong & Lam, 1999) 10. Response Styles to Depression Questionnaire (Nolen-Hoeksema & Morrow, 1991) 11. Stephenson Medication Adherence Interview (Stephenson et al., 1993) adapted for use as a self-report instrument Measured at 3 months (half way through trial) and 6 months (trial end)

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026